Advertisement

Topics

Noonan/Russo Limited Company Profile

09:50 EDT 24th September 2018 | BioPortfolio

We help our clients build and implement strategies for managing the flow of information to the financial, media and scientific communities: shareholders, opinion leaders, analysts, investors, venture capitalists, industry collaborators, journalists, healthcare providers, payors and consumers.

Since 1988, Noonan Russo Presence has represented hundreds of companies that have shaped the biotechnology and healthcare sectors and many of the leaders in science and pharmaceuticals. We understand the challenges and complexities of these businesses and the most effective and efficient ways to meet the needs and interests of their key audiences.

Location

15 Basinghall Street
London
EC2V 5BR
United Kingdom

Contact

Phone: 0207 726 4452
Fax: 0207 726 4453


News Articles [35 Associated News Articles listed on BioPortfolio]

Pacific island bones likely those of Amelia Earhart: study

Bones found on a remote South Pacific island that were originally believed to be those of a man may in fact be those of famed aviatrix Amelia Earhart, who disappeared in the area in 1937, according to...

Full Panel: Is Stormy Daniels About An Affair, or Campaign Finance Rules?

Andrea Mitchell, Peggy Noonan, Eugene Robinson and Matt Bai respond to the latest news in the Stormy Daniels affair and question whether the issue is moral or legal.

Law Professors File Amicus Brief Supporting En Banc Rehearing of Ariosa v. Sequenom

A group of 23 law professors, myself included, have filed an amicus brief in support of en banc rehearing of Ariosa v. Sequenom. The brief is available here.Adam Mossoff, a professor at George Ma...

Quotient Limited Announces Details of Investor Day

JERSEY, Channel Islands, July 16, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced details of its investor day held at the NASDAQ he...

Quotient Limited to Host Investor Day on July 16, 2018

JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it will host an Investor Day on Monday, July ...

Genetic Technologies Limited: Project Shivom Strategic Alliance

MELBOURNE, Australia, March 06, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG)  (NASDAQ:GENE) (“Company”, “GTG”) a diversified molecular diagnostics company; provider of...

Quotient Limited appoints Franz Walt as Chief Executive Officer

JERSEY, Channel Islands, May 29, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Franz Walt, as its Chief Executi...

Quotient Limited Reports Commencement of EU Blood Grouping Field Trial

JERSEY, Channel Islands, May 17, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today reported that it has completed the verification and validatio...

PubMed Articles [15 Associated PubMed Articles listed on BioPortfolio]

Cardiovascular disease in Noonan syndrome.

To provide information on the scope of cardiac disease in Noonan syndrome.

Comparative assessment of gene-specific variant distribution in prenatal and postnatal cohorts tested for Noonan syndrome and related conditions.

To compare the pattern of gene-specific involvement and the spectrum of variants observed in prenatal and postnatal (mean ± SD, 8.9 ± 9.4 years) cohorts tested for Noonan syndrome and related co...

The Rasopathy family: Consequences of germline activation of the RAS/MAPK pathway.

Noonan syndrome (NS; Mendelian Inheritance in Men (MIM) ♯163950) and related syndromes (Noonan syndrome with multiple lentigines (NS-ML, formerly called LEOPARD syndrome; MIM ♯151100), Noonan-like...

Untangling Neural Representations in the Motor Cortex.

How the brain generates accurate movement is a long-standing problem in neuroscience. In this issue of Neuron, Russo et al. (2018) argue that population activity in motor cortex does not represent mu...

Cleft palate and hypopituitarism in a patient with Noonan-like syndrome with loose anagen hair-1.

Noonan syndrome (NS), the most common of the RASopathies, is a developmental disorder caused by heterozygous germline mutations in genes encoding proteins in the RAS-MAPK signaling pathway. Noonan-lik...

Clinical Trials [7 Associated Clinical Trials listed on BioPortfolio]

Research Study Using Recombinant Human Insulin-Like Growth Factor-1/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 for Children With Noonan Syndrome

The trial will investigate the treatment of growth failure in children with Noonan syndrome. Abnormalities in the growth hormone (GH) – insulin-like growth factor-I (IGF-I) axis resultin...

Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan Syndrome

This study evaluate the efficacy of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-COA) reductase inhibitors, also known as "statins" in the treatment of growth and skeletal abnormalities in c...

Hormonal Sensitivity in Patients With Noonan and LEOPARD Syndromes

Noonan and LEOPARD syndromes share, with variable severity, different clinical traits, notably craniofacial manifestations, cardiopathies, short stature, and juvenile cancers. The main ge...

Effect of MAXOMAT ® on the Growth of Small Children to NOONAN's Syndrome

1. Clinical Objective : To improve the growth of these children 2. Genetic objective : A study of the genetics of the syndrome

Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome

This trial is conducted in Asia. The aim of this trial is to investigate the long-term efficacy and safety of two doses of NN-220 (somatropin) in short stature due to Noonan syndrome.

Companies [85 Associated Companies listed on BioPortfolio]

Noonan/Russo Limited

We help our clients build and implement strategies for managing the flow of information to the financial, media and scientific communities: shareholders, opinion leaders, analysts, investors, venture ...

Russo Partners, LLC

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

More Information about "Noonan/Russo Limited" on BioPortfolio

We have published hundreds of Noonan/Russo Limited news stories on BioPortfolio along with dozens of Noonan/Russo Limited Clinical Trials and PubMed Articles about Noonan/Russo Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Noonan/Russo Limited Companies in our database. You can also find out about relevant Noonan/Russo Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record